Table 4: Baseline characteristics of patients and lesions in the propensity-matched cohorts.

VariablesDCB-iRA lesions 
(n=41)
nDES-iRA lesions 
(n=41)
P value

Number of patients3435
Age (years)70±872±90.63
Male (%)24 (70.6)20(57.1)0.32
Smoking (%)6 (17.6)10 (28.6)0.39
Diabetes (%)22 (64.7)17 (48.6)0.23
Hypertension (%)24(70.6)28 (80.0)0.41
Hyperlipidemia (%)22 (64.7)22(62.9)1.00
Chronic kidney disease (%)13 (38.2)14 (40.0)1.00
Hemodialysis patients (%)10 (29.4)12 (34.3)0.80
Previous MI (%)11 (32.4)7 (20.0)0.28
Previous CABG (%)3 (8.8)1(2.9)0.36
PAD (%)10 (29.4)12 (34.3)0.80
Target vessel
  LMT (%)2 (4.9)2 (4.9)0.79
  LAD (%)23 (56.1)21 (51.2)
  RCA (%)9(22.0)13(31.7
  LCX (%)7 (17.1)5 (12.2)
Lesion anatomy
 Type B2/C (%)41(100)39 (95.1)0.60
 Ostial (%)10 (24.4)10(24.4)1.0
 Bifurcation (%)24 (58.5)23 (56.1)1.0
 CTO (%)3 (7.3)5 (12.2)0.71
Quantitative angiography
 Reference diameter (mm)2.44±0.632.39±0.420.66
 Lesion length (mm)14.29±6.8414.67±6.000.79
MLD
 Pre-intervention (mm)0.93±0.390.87±0.350.43
 Percent diameter stenosis
Pre-intervention (%)61.43±14.4764.67±15.340.33
Mean burr size (mm)1.78±0.321.66±0.180.028
B/A ratio0.76±0.140.71±0.120.10

Abbreviations are the same for Table 1.